Prospective phase II study of preoperative short-course radiotherapy for rectal cancer with twice daily fractions of 2.9 Gy to a total dose of 29 Gy--long-term results
about
Neoadjuvant vs adjuvant pelvic radiotherapy for locally advanced rectal cancer: Which is superior?Neoadjuvant short-course hyperfractionated accelerated radiotherapy (SC-HART) combined with S-1 for locally advanced rectal cancerLocally advanced rectal cancer: a comparison of management strategies.Literature review: preoperative radiotherapy and rectal cancer - impact on acute symptom presentation and quality of life.
P2860
Prospective phase II study of preoperative short-course radiotherapy for rectal cancer with twice daily fractions of 2.9 Gy to a total dose of 29 Gy--long-term results
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Prospective phase II study of ...... se of 29 Gy--long-term results
@ast
Prospective phase II study of ...... se of 29 Gy--long-term results
@en
Prospective phase II study of ...... e of 29 Gy--long-term results.
@nl
type
label
Prospective phase II study of ...... se of 29 Gy--long-term results
@ast
Prospective phase II study of ...... se of 29 Gy--long-term results
@en
Prospective phase II study of ...... e of 29 Gy--long-term results.
@nl
prefLabel
Prospective phase II study of ...... se of 29 Gy--long-term results
@ast
Prospective phase II study of ...... se of 29 Gy--long-term results
@en
Prospective phase II study of ...... e of 29 Gy--long-term results.
@nl
P2093
P2860
P356
P1433
P1476
Prospective phase II study of ...... se of 29 Gy--long-term results
@en
P2093
Andreas Thalheimer
Arnulf Thiede
Daniel Wehner
Gottfried Müller
Joern Wulf
Marco Sailer
Michael Flentje
P2860
P2888
P356
10.1186/1748-717X-4-67
P577
2009-12-21T00:00:00Z
P6179
1006983960